SHIRE DEVELOPMENT LLC v. INVAGEN PHARMACEUTICALS, INC., 15-cv-0367 (SRC)(CLW). (2016)
Court: District Court, D. New Jersey
Number: infdco20160516a10
Visitors: 2
Filed: May 13, 2016
Latest Update: May 13, 2016
Summary: NOT FOR PUBLICATION ORDER CATHY L. WALDOR , Magistrate Judge . THIS MATTER comes before the Court on the motion to strike (ECF No. 72) filed by Plaintiffs. Having considered the parties' submissions (ECF Nos. 72, 75, 76), the Court concludes that, in light of the Court's recent Order granting the motion to amend (ECF No. 77), Plaintiffs' arguments in support of its motion are now moot. Therefore, the motion to strike Defendant's invalidity and unenforceability contentions is hereby denie
Summary: NOT FOR PUBLICATION ORDER CATHY L. WALDOR , Magistrate Judge . THIS MATTER comes before the Court on the motion to strike (ECF No. 72) filed by Plaintiffs. Having considered the parties' submissions (ECF Nos. 72, 75, 76), the Court concludes that, in light of the Court's recent Order granting the motion to amend (ECF No. 77), Plaintiffs' arguments in support of its motion are now moot. Therefore, the motion to strike Defendant's invalidity and unenforceability contentions is hereby denied..
More
NOT FOR PUBLICATION
ORDER
CATHY L. WALDOR, Magistrate Judge.
THIS MATTER comes before the Court on the motion to strike (ECF No. 72) filed by Plaintiffs. Having considered the parties' submissions (ECF Nos. 72, 75, 76), the Court concludes that, in light of the Court's recent Order granting the motion to amend (ECF No. 77), Plaintiffs' arguments in support of its motion are now moot. Therefore, the motion to strike Defendant's invalidity and unenforceability contentions is hereby denied.
The parties shall submit a joint status letter, via CM/ECF, regarding the production of ANDA samples by May 18, 2016.
Source: Leagle
